Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chinaski who wrote (18946)	4/12/1998 11:15:00 AM
From: Hippieslayer	Read Replies (1) of 32384

I agree that KS has a very small target population (mostly those suffering from AIDS) but what I'm curious about is whether or not PAnretin has any off label uses that we might not know about. I have long thought that lgnd positioned Panretin for KS solely because it affects those with full blown AIDS-which is the kingdaddy of PC diseases. I think the fda will be more kind to drug makers who make drugs for the Red ribbon crowd and I think lgnd is appropriately taken advantage of it. And the fact that the drug works is great. Hopefully it will see other uses that will make it more worthwhile for LGND and us shareholders. Happy Easter, Passover, etc. Fugazi

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next